Catalyst Wire Dossier Catalyst Wire Dossier

Methoxyetomidate Hydrochloride for Injection

Methoxyetomidate Hydrochloride for Injection · Ahon Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Methoxyetomidate Hydrochloride for Injection, covering 2024-01-12 to 2024-01-12. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of Methoxyetomidate Hydrochloride for Injection (ET-26) for the Induction of General Anesthesia in Elective Surgery Subjects [Phase 3]

See pricing